U.S. markets open in 7 hours 14 minutes
  • S&P Futures

    3,886.75
    +19.25 (+0.50%)
     
  • Dow Futures

    31,503.00
    +145.00 (+0.46%)
     
  • Nasdaq Futures

    13,152.00
    +96.75 (+0.74%)
     
  • Russell 2000 Futures

    2,256.50
    +27.40 (+1.23%)
     
  • Crude Oil

    60.04
    +0.29 (+0.49%)
     
  • Gold

    1,730.70
    -2.90 (-0.17%)
     
  • Silver

    26.73
    -0.15 (-0.55%)
     
  • EUR/USD

    1.2088
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.4150
    0.0000 (0.00%)
     
  • Vix

    24.10
    +0.75 (+3.21%)
     
  • GBP/USD

    1.3958
    +0.0002 (+0.01%)
     
  • USD/JPY

    106.8730
    +0.1630 (+0.15%)
     
  • BTC-USD

    49,608.27
    +1,028.12 (+2.12%)
     
  • CMC Crypto 200

    996.82
    +8.72 (+0.88%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Syneos Health Inc (SYNH) CEO Alistair Macdonald Sold $4.9 million of Shares

GuruFocus.com
·2 min read

- By insider

CEO of Syneos Health Inc (30-Year Financial, Insider Trades) Alistair Macdonald (insider trades) sold 64,497 shares of SYNH on 02/02/2021 at an average price of $75.71 a share. The total sale was $4.9 million.


Syneos Health Inc is a Contract Research Organization providing clinical development services for biopharmaceutical & medical device industries. It operates in North America, Europe, Middle East and Africa, Asia-Pacific and Latin America. Syneos Health Inc has a market cap of $8.05 billion; its shares were traded at around $77.420000 with a P/E ratio of 42.55 and P/S ratio of 1.82. Syneos Health Inc had annual average EBITDA growth of 17.40% over the past five years. GuruFocus has detected 4 severe warning signs with Syneos Health Inc. .

CEO Recent Trades:

  • CEO Alistair Macdonald sold 64,497 shares of SYNH stock on 02/02/2021 at the average price of $75.71. The price of the stock has increased by 2.26% since.

CFO Recent Trades:

  • CFO Jason M. Meggs sold 5,552 shares of SYNH stock on 01/06/2021 at the average price of $72. The price of the stock has increased by 7.53% since.

Directors and Officers Recent Trades:

  • Pres., Clinical Solutions Paul Colvin sold 8,486 shares of SYNH stock on 02/01/2021 at the average price of $74.82. The price of the stock has increased by 3.48% since.

  • General Counsel & Corp Secty Jonathan Olefson sold 5,336 shares of SYNH stock on 01/25/2021 at the average price of $75.68. The price of the stock has increased by 2.3% since.

  • Pres., Commercial Solutions Michelle Keefe sold 4,000 shares of SYNH stock on 01/25/2021 at the average price of $75.68. The price of the stock has increased by 2.3% since.

For the complete insider trading history of SYNH, click here

.This article first appeared on GuruFocus.